Alterity Therapeutics (ATHE) Other Operating Expenses (2010 - 2019)
Alterity Therapeutics (ATHE) posted quarterly Other Operating Expenses of $87328.6 for Q4 2019, down 38.92% year-over-year from $142967.8 in Q4 2018, and down 38.92% quarter-over-quarter from $142967.8 in Q4 2018.
Alterity Therapeutics (ATHE) Other Operating Expenses (2010 - 2019) Analysis & Trends
Alterity Therapeutics' Other Operating Expenses history runs 7 years deep, the most recent figure standing at $87328.6 for Q4 2019.
- In Q4 2019, Other Operating Expenses fell 38.92% year-over-year to $87328.6; the TTM figure through Jun 2021 stood at $87328.6 (down 62.08% YoY), while the FY2025 annual figure was -$42980.1, down 124.97% from the prior year.
- Other Operating Expenses for Q4 2019 stood at $87328.6, down from $142967.8 in the prior quarter.
- The five-year high for Other Operating Expenses was $12.3 million in Q4 2015, with the low at -$469835.6 in Q4 2017.
- The 5-year median for Other Operating Expenses is $142967.8 (2018), against an average of $2.5 million.
- The sharpest annual moves came in 2017 and 2018: Other Operating Expenses plunged 226.27% in 2017, then jumped 130.43% in 2018.
- Alterity Therapeutics' Other Operating Expenses stood at $12.3 million in 2015, then slumped by 96.98% to $372092.8 in 2016, then slumped by 226.27% to -$469835.6 in 2017, then soared by 130.43% to $142967.8 in 2018, then tumbled by 38.92% to $87328.6 in 2019.
- Business Quant data shows ATHE's Other Operating Expenses at $87328.6 in Q4 2019, $142967.8 in Q4 2018, and -$469835.6 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Alterity Therapeutics | 48.56 Mn | 16.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 87,328.62 |
| Dec 31, 2018 | 142,967.80 |
| Dec 31, 2017 | -469,835.65 |
| Dec 31, 2016 | 372,092.82 |
| Dec 31, 2015 | 12.33 Mn |
| Dec 31, 2014 | 15.06 Mn |
| Dec 31, 2010 | -5,488.00 |